SCHEMBL8287908

SCHEMBL8287908

Cc1cc(NCc2ccccc2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.45
KDM4E B2RXH2 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 7/20 0.43
LMNA P02545 4/20 0.43
HTT P42858 3/20 0.43
GPR55 Q9Y2T6 1/20 0.43
USP2 O75604 2/20 0.40
MAPK1 P28482 2/20 0.40
ALOX15 P16050 1/20 0.40
MAT2A P31153 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287864 0.93 PDE11A (0.44) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL8358815 0.91 MAPT (0.45) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5871799 0.88 PDE11A (0.50) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL8287115 0.86 PDE11A (0.44) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL8287137 0.86 PDE11A (0.44) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL8285142 0.86 PDE11A (0.60) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5871404 0.85 PDE11A (0.44) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5872118 0.84 PDE11A (0.46) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL8285161 0.84 PDE11A (0.47) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL8285163 0.83 POLB (0.50) PDE11AKDM4ESMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed